Literature DB >> 26071295

Successful endovascular treatment of severe chronic mesenteric ischemia by concurrent triple-vessel mesenteric artery revascularization.

George Joseph1, Sunil Agarwal2.   

Abstract

A 52-year-old man presenting with severely symptomatic chronic mesenteric ischemia had proximal occlusion of the celiac and superior mesenteric arteries and critical stenosis of the inferior mesenteric artery ostium. Concurrent percutaneous revascularization with stenting of all three mesenteric arteries was successfully achieved using techniques tailored to each lesion. Complete clinical recovery was observed at the six-month post-procedure follow-up.
Copyright © 2015 Cardiological Society of India. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Angioplasty; Peripheral vascular; Recanalization; Stenting; Transcatheter therapy

Mesh:

Year:  2015        PMID: 26071295      PMCID: PMC4475817          DOI: 10.1016/j.ihj.2015.03.002

Source DB:  PubMed          Journal:  Indian Heart J        ISSN: 0019-4832


  15 in total

1.  Percutaneous retrograde recanalization of the celiac artery by way of the superior mesenteric artery for chronic mesenteric ischemia.

Authors:  George Joseph; Sujith Thomas Chacko
Journal:  Cardiovasc Intervent Radiol       Date:  2012-04-14       Impact factor: 2.740

2.  Technique of recanalization of long-segment flush superior mesenteric artery occlusions.

Authors:  Rafael D Malgor; Gustavo S Oderich
Journal:  Vasc Endovascular Surg       Date:  2011-09-07       Impact factor: 1.089

3.  Endovascular treatment of totally occluded superior mesenteric artery by retrograde crossing via the Villemin arcade.

Authors:  Carlo Ferro; Umberto G Rossi; Sara Seitun; Giulio Bovio; Rosario Fornaro
Journal:  Cardiovasc Intervent Radiol       Date:  2012-08-25       Impact factor: 2.740

4.  Comparison of covered stents versus bare metal stents for treatment of chronic atherosclerotic mesenteric arterial disease.

Authors:  Gustavo S Oderich; Luke S Erdoes; Christopher Lesar; Bernardo C Mendes; Peter Gloviczki; Stephen Cha; Audra A Duncan; Thomas C Bower
Journal:  J Vasc Surg       Date:  2013-07-01       Impact factor: 4.268

5.  Mesenteric artery complications during angioplasty and stent placement for atherosclerotic chronic mesenteric ischemia.

Authors:  Gustavo S Oderich; Tiziano Tallarita; Peter Gloviczki; Audra A Duncan; Manju Kalra; Sanjay Misra; Stephen Cha; Thomas C Bower
Journal:  J Vasc Surg       Date:  2012-02-08       Impact factor: 4.268

6.  Intermediate-term outcomes of endovascular treatment for symptomatic chronic mesenteric ischemia.

Authors:  Michael A Peck; Mark F Conrad; Christopher J Kwolek; Glenn M LaMuraglia; Vikram Paruchuri; Richard P Cambria
Journal:  J Vasc Surg       Date:  2009-10-17       Impact factor: 4.268

7.  Patient survival after open and endovascular mesenteric revascularization for chronic mesenteric ischemia.

Authors:  Tiziano Tallarita; Gustavo S Oderich; Peter Gloviczki; Audra A Duncan; Manju Kalra; Stephen Cha; Sanjay Misra; Thomas C Bower
Journal:  J Vasc Surg       Date:  2013-01-17       Impact factor: 4.268

8.  A comparison of open and endovascular revascularization for chronic mesenteric ischemia in a clinical decision model.

Authors:  Wouter Hogendoorn; M G Myriam Hunink; Felix J V Schlösser; Frans L Moll; Bart E Muhs; Bauer E Sumpio
Journal:  J Vasc Surg       Date:  2014-04-08       Impact factor: 4.268

Review 9.  Chronic mesenteric ischemia: critical review and guidelines for management.

Authors:  Felice Pecoraro; Zoran Rancic; Mario Lachat; Dieter Mayer; Beatrice Amann-Vesti; Thomas Pfammatter; Guido Bajardi; Frank J Veith
Journal:  Ann Vasc Surg       Date:  2012-10-23       Impact factor: 1.466

Review 10.  Bowel necrosis following endovascular revascularization for chronic mesenteric ischemia: a case report and review of the literature.

Authors:  Takuro Shirasu; Akihiro Hosaka; Hiroyuki Okamoto; Kunihiro Shigematsu; Yasushi Takeda; Tetsuro Miyata; Toshiaki Watanabe
Journal:  BMC Gastroenterol       Date:  2013-07-19       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.